We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


EMA Binding Assay (HS Screen)

General information

The assay is useful in the diagnosis of Hereditary Spherocytosis (HS). The results should be interpreted alongside a full blood count and morphological assessment of a peripheral blood film.

Specimen transport: At room temperature.

Repeat frequency: At significant change of clinical symptoms.

Special precautions: The assay should be carried out on blood that is <24 hours old. Samples can be stored at 4°C prior to analysis.

Laboratory information

Normal reference range: Normal

Volume and sample type: 5ml EDTA blood

Method: Flow cytometry

Turnaround time (calendar days from sample receipt to authorised result): Median - 4

Clinical information

Indications for the test: Diagnosis of Hereditary Spherocytosis

Factors affecting the test: The test is not recommended for use on infants who are <1 year old as there is an increased likelihood of a false positive result.


ICE reference: HS Screen


(Last updated August 22nd 2018)